Next Article in Journal
Validity and Reliability of General Nutrition Knowledge Questionnaire for Adults in Uganda
Next Article in Special Issue
Effects of Fruit and Vegetable Consumption on Risk of Asthma, Wheezing and Immune Responses: A Systematic Review and Meta-Analysis
Previous Article in Journal
Metabolic Effects of Glucose-Fructose Co-Ingestion Compared to Glucose Alone during Exercise in Type 1 Diabetes
Previous Article in Special Issue
Maternal Folic Acid Supplementation during Pregnancy and Childhood Allergic Disease Outcomes: A Question of Timing?

Hypoallergenic Variant of the Major Egg White Allergen Gal d 1 Produced by Disruption of Cysteine Bridges

Neuro Allergy Research Laboratory (NARL), School of Life and Environmental Sciences, Faculty of Science, Engineering and Built Environment, Deakin University, 75 Pigdons Road, Geelong 3216 VIC, Australia
Australian Animal Health Laboratory (AAHL), Biosecurity Flagship, Commonwealth Scientific and Industrial Research Organisation (CSIRO), 5 Portarlington Road, East Geelong 3219 VIC, Australia
Poultry CRC, P.O. Box U242, University of New England, Armidale 2351 NSW, Australia
Department of Orthopedic Surgery, Brigham and Women’s Hospital, Harvard Medical School, 60 Fenwood Road, Boston, 02115 MA, USA
Department of Allergy and Immunology, Royal Children’s Hospital, 50 Flemington Road, Parkville 3052 VIC, Australia
Allergy and Immune Disorders, Murdoch Children’s Research Institute, 50 Flemington Road, Parkville 3052 VIC, Australia
The University of Melbourne, Parkville 3010 VIC, Australia
Author to whom correspondence should be addressed.
Nutrients 2017, 9(2), 171;
Received: 8 November 2016 / Revised: 9 February 2017 / Accepted: 15 February 2017 / Published: 21 February 2017
(This article belongs to the Special Issue Nutrition and Allergic Diseases)
Background: Gal d 1 (ovomucoid) is the dominant allergen in the chicken egg white. Hypoallergenic variants of this allergen can be used in immunotherapy as an egg allergy treatment approach. We hypothesised that disruption of two of the nine cysteine-cysteine bridges by site-directed mutagenesis will allow the production of a hypoallergenic variant of the protein; Methods: Two cysteine residues at C192 and C210 in domain III of the protein were mutated to alanine using site-directed mutagenesis, to disrupt two separate cysteine-cysteine bridges. The mutated and non-mutated proteins were expressed in Escherichia coli (E. coli) by induction with isopropyl β-d-1-thiogalactopyranoside (IPTG). The expressed proteins were analysed using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting to confirm expression. Immunoglobulin E (IgE) reactivity of the two proteins was analysed, by immunoblotting, against a pool of egg-allergic patients’ sera. A pool of non-allergic patients’ sera was also used in a separate blot as a negative control; Results: Mutant Gal d 1 showed diminished IgE reactivity in the immunoblot by showing lighter bands when compared to the non-mutated version, although there was more of the mutant protein immobilised on the membrane when compared to the wild-type protein. The non-allergic negative control showed no bands, indicating an absence of non-specific binding of secondary antibody to the proteins; Conclusion: Disruption of two cysteine bridges in domain III of Gal d 1 reduces IgE reactivity. Following downstream laboratory and clinical testing, this mutant protein can be used in immunotherapy to induce tolerance to Gal d 1 and in egg allergy diagnosis. View Full-Text
Keywords: allergens; egg allergy; immunotherapy; hypoallergens allergens; egg allergy; immunotherapy; hypoallergens
Show Figures

Figure 1

MDPI and ACS Style

Dhanapala, P.; Withanage-Dona, D.; Tang, M.L.K.; Doran, T.; Suphioglu, C. Hypoallergenic Variant of the Major Egg White Allergen Gal d 1 Produced by Disruption of Cysteine Bridges. Nutrients 2017, 9, 171.

AMA Style

Dhanapala P, Withanage-Dona D, Tang MLK, Doran T, Suphioglu C. Hypoallergenic Variant of the Major Egg White Allergen Gal d 1 Produced by Disruption of Cysteine Bridges. Nutrients. 2017; 9(2):171.

Chicago/Turabian Style

Dhanapala, Pathum, Dulashi Withanage-Dona, Mimi L.K. Tang, Tim Doran, and Cenk Suphioglu. 2017. "Hypoallergenic Variant of the Major Egg White Allergen Gal d 1 Produced by Disruption of Cysteine Bridges" Nutrients 9, no. 2: 171.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop